A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer

Published:2014-07 Issue:1 Volume:211 Page:68.e1-68.e8
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Krivak Thomas C.,Lele Shashikant,Richard Scott,Secord Angeles Alvarez,Leath Charles A.,Brower Stacey L.,Tian Chunqiao,Moore Richard G.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference23 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

2. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study;Ozols;J Clin Oncol,2003

3. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer;du Bois;J Natl Cancer Inst,2003

4. Latest research and treatment of advanced-stage epithelial ovarian cancer;Coleman;Nat Rev Clin Oncol,2013

5. Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube or primary peritoneal cancer (JGOG 3016): a randomized, controlled, open-label trial;Katsumata;Lancet Oncol,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep learning magnetic resonance imaging predicts platinum sensitivity in patients with epithelial ovarian cancer;Frontiers in Oncology;2022-11-23

2. Transcriptional epigenetic regulation of Fkbp1/Pax9 genes is associated with impaired sensitivity to platinum treatment in ovarian cancer;Clinical Epigenetics;2021-08-28

3. Real-world clinical practice patterns and outcomes for advanced ovarian cancer in Spain (GEICO-42-R study);European Journal of Gynaecological Oncology;2021

4. A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer;International Journal of Molecular Sciences;2020-07-07

5. S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer;International Journal of Molecular Sciences;2018-12-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3